Sign In
Buy KMDA
$7.39
-0.120 (-1.60%)
At Close: Jun 03, 2026
Kamada Reports Second Quarter and First Six Months of 2020 Financial Results, Recent Corporate Achievements and Strong Cash Position
11:00am, Wednesday, 12'th Aug 2020
* Second Quarter Revenues were $33.1 million, Compared to $35.3 million in 2019, First Half 2020 Revenues were $66.4 million, up 7% from 2019 * Net Income for the Second Quarter and for the First
Kamada's Earnings: A Preview
02:27pm, Tuesday, 11'th Aug 2020
On Wednesday, August 12, Kamada (NASDAQ: KMDA) will release its latest earnings report. Here is Benzinga's outlook for the company.Earnings and Revenue Kamada EPS will likely be near $0.11 while reven
* Study Participants are Hospitalized, Non-ventilated COVID-19 Patients with Pneumonia * Encouraging Neutralization Activity Observed with Virus Neutralization Assay * Pre-IND Meeting with U.S.
Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Host Conference Call on August 12, 2020
11:00am, Wednesday, 05'th Aug 2020
REHOVOT, Israel, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the second qu
The 1 Promising Coronavirus Stock No One Knows About Yet
11:20am, Friday, 31'st Jul 2020
Perhaps the least-known COVID-19 stock on the market right now is a small Israel-based biotech company called Kamada (NASDAQ: KMDA). What is Kamada? Despite having gone public on the NASDAQ in 2013,
Analysts Estimate Kamada (KMDA) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Jul 2020
Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kamada: Under-The-Radar COVID-19 Therapy Play With Downside Protection And Margin Of Safety
10:51am, Wednesday, 22'nd Jul 2020
US and global pharma companies that are working on credible COVID-19 treatments are up massively YTD, often more than 100% and far surpassing performance of general pharma indices.
Kamada (KMDA) Looks Good: Stock Adds 5.7% in Session
12:46pm, Thursday, 25'th Jun 2020
Kamada (KMDA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Price Over Earnings Overview: Kamada
02:45pm, Wednesday, 24'th Jun 2020
In the current session, Kamada Inc. (NASDAQ: KMDA) is trading at $9.70, after a 8.52% increase. Over the past month, the stock increased by 23.43%, and in the past year, by 79.00%. With performance li
Kamada’s Covid-19 Therapy Approved For Compassionate Use In Israel
12:26pm, Wednesday, 17'th Jun 2020
Biopharma Kamada Ltd (KMDA) has announced that the initial vials of its plasma-derived immunoglobulin (IgG) product for Covid-19 have received the green light for compassionate use in Israel.The compa
Kamada Completed Manufacturing and Released the First Batch of its Plasma-Derived Immunoglobulin Product for Coronavirus Disease (COVID-19) and it is Available for Compassionate.
How Kamada (KMDA) Stock Stands Out in a Strong Industry
02:29am, Saturday, 13'th Jun 2020
Kamada (KMDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
